Welcome to our dedicated page for Protect Pharmace news (Ticker: PRTT), a resource for investors and traders seeking the latest updates and insights on Protect Pharmace stock.
Protect Pharmace (PRTT) is a pharmaceutical innovator focused on advanced drug research and therapeutic development. This page serves as the definitive source for official company announcements, press releases, and industry-related news updates.
Investors and industry professionals will find timely information on clinical trial progress, regulatory milestones, and strategic partnerships. Our curated feed includes updates across key areas:
• Earnings reports & financial disclosures
• Drug development breakthroughs
• Manufacturing quality certifications
• Regulatory compliance achievements
Bookmark this page for direct access to Protect Pharmace's verified announcements, presented with context for both expert analysts and general readers. Check regularly for developments shaping the company's position in the global pharmaceutical landscape.
Protect Pharmaceutical Corp. (OTC: PRTT) has announced that its previously reported merger with KARINCA Logistics will not proceed. The announcement made on August 28, 2024, regarding the merger should be disregarded. An unforeseen business issue emerged during the final due diligence process at closing, leading to the termination of the deal. No shares or monetary exchange took place between the parties. The company's management states that current plans do not involve KARINCA Logistics, and they will continue to update shareholders on future progress. Additionally, Director George Athanasiadis has resigned from the board of directors.
Protect Pharmaceutical Corp. (OTC: PRTT) has finalized its merger with KARINCA Logistics, a move expected to significantly enhance the company's operations. The merger brings valuable assets including a large network, important routes, and expanded sales opportunities across Europe and Asia. To complete the deal, PRTT issued 1,000,000 additional Preferred Shares with 100:1 voting rights, avoiding common share dilution.
CEO Ozgur Ozcan emphasized that the company's priority is now to complete the PCAOB audit, file a FORM 10 registration statement, and resume SEC reporting in preparation for an exchange uplisting. The merger is anticipated to generate new revenue streams and profitability for PRTT in the current calendar year.
Protect Pharmaceutical Corp. (OTC: PRTT) has announced significant changes in its leadership and a pending merger with Karinca Logistics. Ozgur Ozcan has been appointed as the new CEO and Director, while George Athanasiadis joins as a Director. These appointments come alongside the resignations of Ali Yildiz as CEO and Tatiana Aleinikov as VP of Operations.
The company is in the final stages of merging with Karinca Logistics, a move expected to boost revenue and profitability. PRTT plans to provide shareholders with an update on the merger and pending audit within a week. The company also intends to file a Form 10 registration with the SEC to resume reporting standards and aims to uplist to an exchange. A company name change is also in the works to better reflect its current business focus.
Protect Pharmaceutical Corp. (OTC: PRTT) is nearing the completion of its PCAOB audit for fiscal year 2023, with only a few pending items in Turkey. The company plans to file a Form 10 and apply for an uplist upon audit completion. Additionally, the company plans a corporate name and symbol change to Atlantic Logistics. Protect Pharmaceutical is also finalizing a merger with Karinca Logistics, a major Turkish logistics company. This merger is expected to increase revenues by 2.5 times, surpassing $250 million, and significantly boost profitability. The merger will reintroduce profitable transit routes halted due to geopolitical issues and open new opportunities in Asia. This strategic move aims to expand the company's reach, storage, and transit capacities, positioning it as a global logistics leader.
FAQ
What is the current stock price of Protect Pharmace (PRTT)?
What is the market cap of Protect Pharmace (PRTT)?
